CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,048 | +211.2% | 1,690 | +154.1% | 0.00% | – |
Q2 2023 | $14,796 | -73.2% | 665 | -73.9% | 0.00% | – |
Q1 2023 | $55,211 | -99.4% | 2,549 | -99.5% | 0.00% | -100.0% |
Q3 2020 | $8,703,000 | +38.4% | 500,000 | +25.0% | 0.04% | +80.0% |
Q2 2018 | $6,288,000 | – | 400,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
S&T BANK/PA | 346,306 | $7,033 | 1.30% |
Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |